Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Feb 16;20(11):2474–2484.e3. doi: 10.1016/j.cgh.2022.02.017

Table 1:

Characteristics of EGID nomenclature Delphi process (n=85)

n (%), or median
Sex
 Female 32 (38)
 Male 53 (62)
Time in practice (median years, IQR, range) 21 (9–30); range: 1–44
Specialty
 Gastroenterology 60 (70)
 Allergy/Immunology 15 (18)
 Pathology 5 (6)
 Other 5 (6)
Type of patients seen
 Children and/or adolescents 41 (48)
 Adolescents and adults 10 (12)
 Adults 15 (18)
 All ages 12 (14)
 Do not see patients 7 (8)
Practice setting
 Academic/university 77 (91)
 Private/community practice 4 (5)
 Not practicing 3 (3)
 Industry 1 (1)
Location
 North America 49 (58)
 South America 2 (2)
 Europe 24 (28)
 Asia 6 (7)
 Australia 4 (5)
Non-EoE EGID patients seen per month
 <3 33 (47)
 3–5 13 (19)
 5–10 9 (13)
 >10 15 (21)